StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
SKYESkye Bioscience, Inc.
stockpulse.co.kr
Nasdaq
$1.60▲ 5.96%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $56.2MShares out 35.1M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

22
  • 10.14After-hours26.10.15 06:41
    SCHEDULE 13GOwnership#●●●

    Skye Bioscience, Inc.

    Tang Capital Management and its affiliated entities have filed a Schedule 13G to report their joint beneficial ownership of Skye Bioscience, Inc. common stock. This filing formalizes the collective holding of shares by the entities managed by Kevin Tang.…more

    $1.60+5.96%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.24After-hours26.09.25 05:31
    4Ownership

    Skye Bioscience, Inc.

    Insider Andrew J. Schwab of Skye Bioscience, Inc. filed a Form 4 report on September 24, 2026, regarding changes in beneficial ownership of securities as of September 22, 2026.…more

    $1.60+5.96%vs prev close
    View filingShare
  • 9.24After-hours26.09.25 05:30
    SCHEDULE 13D/AOwnership

    Skye Bioscience, Inc.

    5AM Partners VII, LLC has filed a SCHEDULE 13D/A regarding its beneficial ownership in Skye Bioscience, Inc. This filing serves to update the status of the investor's equity holdings in the company.…more

    $1.60+5.96%vs prev close
    View filingShare

21 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.11After-hours26.09.12 05:16
    #●●●

    Skye Bioscience CFO Resigns; CEO Punit Dhillon To Assume Financial Oversight…more

    Skye Bioscience announced that CFO John Sharp will resign effective September 8, with CEO Punit Dhillon taking over as the principal financial and accounting officer. This sudden leadership change in the finance department may introduce uncertainty for investors.…more

    $1.60+5.96%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 8.24After-hours26.08.25 05:06

    ●●●●●●●● ●●●●● ●●●●●●

    Skye Bioscience has entered into a securities purchase agreement with an affiliate of Redmile Group to raise up to $22 million. The final funding amount is subject to adjustments based on the proceeds from the company's concurrent PIPE financing.…more

    $1.60+5.96%vs prev close
    ShareBenzinga
  • 8.21After-hours26.08.22 08:50

    ●●●●●●●● ●●●●● ●●●●●●

    Trading of Skye Bioscience shares has been temporarily halted pending the release of significant news. Investors should monitor for upcoming announcements that may impact the stock price.…more

    $1.60+5.96%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →